Stimulation of new blood vessel formation supports the creation of new blood vessels and improves microcirculation
Typically, our clients opt for 6 weekly injections to achieve their best results.
Cagrilintide's C20 fatty-diacid modification extends half-life to ~7 days, making it viable for once-weekly dosing alongside semaglutide or tirzepatide
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
Restores essential electrolytes for optimal b Advanced Myers Cocktail IV $249 Replenish and revitalize with our Myers Cocktail IV Therapy
Results Over the study period, 100 patients were initially enrolled